AmpSure® Neisseria gonorrhoeae RNA Assay is a molecular diagnostic test for the detection and identification of N. gonorrhoeae RNA in clinical specimens. This assay utilizes advanced RNA detection technology to provide rapid and accurate results for gonorrhea diagnosis in clinical settings.
Manufactured by
China
Shanghai Rendu Biotechnology, founded in 2007, is a high-tech enterprise pioneering second-generation molecular diagnostic technology in China. The company develops and manufactures IVD reagents and fully automated instruments for prenatal screening, hand-foot-mouth disease, respiratory pathogens, food safety, and blood testing. ISO13485 certified with 13 registered IVD reagent products and 3 instrument products, serving over 400 medical institutions (70% tertiary hospitals).
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Atila BioSystems
United States · 3 relevant products
GenDx Biotech Co., Ltd.
China · 6 relevant products
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 1 relevant product
71 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →16 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 104 closest product alternatives
Atila BioSystems · United States
A nucleic acid amplification assay for detection of urinary tract infection pathogens including E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and other bacterial species directly from urine specimens without extraction.
GenDx Biotech Co., Ltd. · China
Multiplexed diagnostic assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Ureaplasma urealyticum. Enables comprehensive screening for common urogenital infections.
Atila BioSystems · United States
A molecular assay designed for cervical cancer screening applications utilizing Atila BioSystems nucleic acid amplification chemistry.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products